Jingjing B. Ye
81 Meishan Road
Hefei, 230032, China
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Interim PET response of Pola-R-CHP predicts outcome in previously untreated CD5-positive diffuse large B-cell lymphoma: a multicenter retrospective study.
Journal: Annals of medicine
Published: July 22, 2026
Correction: Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer.
Journal: Journal of nanobiotechnology
Published: April 27, 2026
Integrating ex vivo drug sensitivity and genetic mutation analysis improves prediction of chemotherapy response in acute myeloid leukemia.
Journal: Functional & integrative genomics
Published: January 28, 2026
Clinical Characteristics and Influencing Factors of Depressive Symptoms in Patients With Vascular Cognitive Impairment.
Journal: Actas espanolas de psiquiatria
Published: January 27, 2026
Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.
Journal: Nature communications
Published: December 24, 2025
Correction: Genetic polymorphisms in cGAS-STING-mediated type I interferon innate immune signaling pathway are associated with DLBCL.
Journal: Frontiers in immunology
Published: December 22, 2025
Early prediction of adult lymphoma-associated haemophagocytic lymphohistiocytosis using an interpretable machine learning model.
Journal: British journal of haematology
Published: October 23, 2025
Genetic polymorphisms in cGAS-STING-mediated type I interferon innate immune signaling pathway are associated with DLBCL.
Journal: Frontiers in immunology
Published: October 14, 2025
Construction of a predictive model based on the risk of relapse after cytarabine consolidation therapy in acute myeloid leukemia patients.
Journal: The oncologist
Published: September 25, 2025
Study on the Role of Neutrophil Extracellular Traps-Based Risk Model and Discriminative Gene LTF in the Prognosis of Acute Myeloid Leukemia and the Regulation of Immune Microenvironment.
Journal: Blood and lymphatic cancer : targets and therapy
Published: August 23, 2025
Targeting small ubiquitin-related modifier-specific protease 2 attenuates tumour progression and orchestrates the tumour immune microenvironment in diffuse large B-cell lymphoma.
Journal: British journal of haematology
Published: May 28, 2025
Last Updated: 09/26/2026